SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tema ETF Trust - Tema Space Innovators ETF

The Tema Space Innovators ETF ($NASA) is generating significant buzz as investors look to gain exposure to the broader space economy and high-profile private companies like SpaceX ahead of an anticipated IPO. Community members are actively debating the merits of holding the ETF as a diversified, long-term vehicle versus individual sector plays, with intense interest centered on the fund's specific SpaceX allocation and the momentum building around upcoming aerospace launches.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is trending as investors focus on its role as a key infrastructure partner for SpaceX, with the community actively discussing a recent 9.99% stake acquisition by Citadel and the company's debt-free balance sheet. Market participants are debating the potential for a short squeeze given the stock's low float and the anticipation surrounding the upcoming SpaceX IPO.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

Investors are flocking to XOVR as a liquid and NAV-aligned vehicle to gain indirect exposure to SpaceX, with ongoing community debate comparing its structure to other SpaceX-exposed funds like DXYZ and ARKVX. The primary catalyst fueling discourse is the highly anticipated prospect of a SpaceX IPO, which traders believe could act as a significant price catalyst for the ETF.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is seeing intense community speculation as investors position for a potential short squeeze, fueled by high short interest and aggressive company share buybacks aimed at tightening the float. The stock is a primary focus for traders watching for volatility around earnings, with many pointing to the setup's structural similarities to previous high-profile squeeze plays.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as investors grapple with conflicting macroeconomic signals, including rising U.S. bond yields, shifting geopolitical risks in the Middle East, and persistent inflation concerns. The community is actively debating the ETF's role as a traditional safe-haven hedge versus its recent correlation with equity market volatility, while monitoring central bank accumulation and potential shifts in interest rate policies.

Amplify ETF Trust - Amplify Junior Silver Miners ETF

Amplify Junior Silver Miners ETF

Amplify Junior Silver Miners ETF (SILJ) is trending as community members closely monitor whether the sector will finally see a violent 'catch-up' rally to match the historic price appreciation in physical silver. While some investors argue that juniors are heavily undervalued relative to spot prices and represent a 'coiled spring' ahead of upcoming earnings reports, others are exercising caution due to continued price volatility and the persistent underperformance of miners compared to the underlying metal.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending as investors weigh the company's strong recent revenue growth and expanding sales force against a broader pullback in biotech stocks. The community is actively discussing the upcoming April 30 PDUFA date for the potential approval of Auvelity in treating Alzheimer's disease agitation, which is widely viewed as a major catalyst for future growth.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as investors react to the company's fiscal second-quarter results, which showcased resilience in streaming margins and theme park performance despite a broader market focus on leadership changes and ongoing cost-restructuring efforts. The community is actively debating the stock's long-term growth potential and turnaround narrative, with sentiment split between those optimistic about margin expansion under new leadership and those skeptical of the company's valuation and cultural direction.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is rallying as investors react to headlines regarding a potential diplomatic framework between the U.S. and Iran, with the community actively debating whether this is a legitimate breakthrough or another recurring market-pumping tactic. While some participants are leaning into bullish momentum driven by the prospect of reopened shipping routes and lower energy costs, many remain skeptical of the news and are closely monitoring technical resistance levels for signs of a potential reversal.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is experiencing extreme volatility driven by a major institutional stake disclosure from Leopold Aschenbrenner's fund, which triggered a massive rally and short-squeeze chatter. While the community is debating whether this is a legitimate long-term infrastructure play or a speculative momentum pump, bullish sentiment remains high as traders look for the next leg up toward double digits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates

Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +22.75% and +12.03%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pelthos Therapeutics Inc. (PTHS) Reports Q4 Loss, Tops Revenue Estimates

Pelthos Therapeutics Inc. (PTHS) delivered earnings and revenue surprises of +28.35% and +3.78%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts

Equity

The launch triggered a $5 million milestone payment to Ligand, which also holds a 56% stake in Pelthos and is eligible for royalties and additional commercial milestones.

Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	--	-$6.87	--	N/A
Q2 '26	-$2.82	--	--	N/A
Q1 '26	-$3.45	-$3.09	10.43%	BEAT
Q4 '25	-$3.70	-$6.87	-85.84%	MISSED
Q3 '25	-$0.57	-$5.30	-821.74%	MISSED

PTHS
Pelthos Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings

Compact View

Latest PTHS News

PTHSPelthos Therapeutics Inc.